We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTO to Re-Evaluate Patent Covering Merck’s Singulair
PTO to Re-Evaluate Patent Covering Merck’s Singulair
May 29, 2009
The PTO has decided to re-examine a patent covering Merck’s blockbuster drug Singulair for asthma and allergies.